Detalhe da pesquisa
1.
Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016.
Drug Metab Dispos
; 46(6): 835-845, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572333
2.
Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.
Drug Metab Dispos
; 44(3): 343-51, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26681736
3.
Extending the DIDEO ontology to include entities from the natural product drug interaction domain of discourse.
J Biomed Semantics
; 9(1): 15, 2018 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743102
4.
Developing User Personas to Aid in the Design of a User-Centered Natural Product-Drug Interaction Information Resource for Researchers.
AMIA Annu Symp Proc
; 2018: 279-287, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30815066
5.
Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings.
J Pharm Sci
; 106(9): 2312-2325, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28414144
6.
Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates.
Pharmacotherapy
; 35(4): 361-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25757445
7.
Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics.
Pharmacogenomics
; 15(16): 1947-62, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25521354